A group A Streptococcus ADP-ribosyltransferase toxin stimulates a protective interleukin 1β-dependent macrophage immune response.
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
UNLABELLED: The M1T1 clone of group A Streptococcus (GAS) is associated with severe invasive infections, including necrotizing fasciitis and septicemia. During invasive M1T1 GAS disease, mutations in the covRS regulatory system led to upregulation of an ADP-ribosyltransferase, SpyA. Surprisingly, a GAS ΔspyA mutant was resistant to killing by macrophages and caused higher mortality with impaired bacterial clearance in a mouse intravenous challenge model. GAS expression of SpyA triggered macrophage cell death in association with caspase-1-dependent interleukin 1β (IL-1β) production, and differences between wild-type (WT) and ΔspyA GAS macrophage survival levels were lost in cells lacking caspase-1, NOD-like receptor protein 3 (NLRP3), apoptosis-associated speck-like protein (ASC), or pro-IL-1β. Similar in vitro findings were identified in macrophage studies performed with pseudomonal exotoxin A, another ADP-ribosylating toxin. Thus, SpyA triggers caspase-1-dependent inflammatory cell death in macrophages, revealing a toxin-triggered IL-1β-dependent innate immune response pathway critical in defense against invasive bacterial infection. IMPORTANCE: Group A Streptococcus (GAS) is a leading human pathogen capable of producing invasive infections even in healthy individuals. GAS bacteria produce a toxin called SpyA that modifies host proteins through a process called ADP ribosylation. We describe how macrophages, frontline defenders of the host innate immune system, respond to SpyA by undergoing a specialized form of cell death in which they are activated to release the proinflammatory cytokine molecule interleukin 1β (IL-1β). Release of IL-1β activates host immune cell clearance of GAS, as we demonstrated in tissue culture models of macrophage bacterial killing and in vivo mouse infectious-challenge experiments. Similar macrophage responses to a related toxin of Pseudomonas bacteria were also shown. Thus, macrophages recognize certain bacterial toxins to activate a protective immune response in the host.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![FIG 2 SpyA promotes cell death and caspase-3 activation in a manner independent of MAPK and NF-κB signaling. (A) LIVE/DEAD staining illustrating BMDM viability after 4 h of GAS (AP) infection. Cells were infected at an MOI of ~25 or remained uninfected (UI). Scale bar, 100 µM. (B) Numbers of dead cells were counted from multiple field of views (n = 12). (C) Relative levels of LDH release (percentages compared to uninfected [UI] cells). ΔspyA-infected BMDMs exhibit reduced 2-h cell cytotoxicity at an MOI of 10 or 25. Infection with the SpyA-complemented strain restored LDH release to the WT level (n = 4). Error bars, SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001 (Student’s two-tailed unpaired t test). (D to H) Western blot analysis of whole BMDM lysates after 2 h of GAS infection. β-Actin was used as a loading control. (D) Phospho-ERK1/2 (42 or 44 kDa). (E) Phospho-p-p65 (65 kDa). (F) Apoptosis-inducing factor (AIF; 58 or 68 kDa). (G) Cytochrome c (15 kDa). (H) Caspase-3 (FL, full length [35 kDa]; CLVD, cleaved [17 or 19 kDa]). (I) Capsase-3 and caspace-7 (Caspace-3/7) activity assay. Error bars, SEM. *, P < 0.05; n = 4 (Student’s two-tailed unpaired t test).](https://figures.cochat.ai/paper-figures/8a2a85c40939435aae9a44aeb8e2a766/a-group-a-streptococcus-adp-ribosyltransferase-toxin-stimulates-a-protective-figure-2.jpg)


![FIG 5 GAS SpyA activation of a caspase-1-dependent inflammasome response is required for bacterial clearance by cultured BMDMs and in vivo. (A) BMDMs were coincubated with GAS (AP) at an MOI of 20 plus 10 µM pan-caspase inhibitor zVAD-FMK (ZVAD) or 25 µM caspase-1 inhibitor Ac-YVAD-CHO (YVAD) for 2 h. Data shown are representative of the results of multiple experiments. (B) Relative levels of LDH release (percentages compared to levels in uninfected [UI] cells; left panel) and bacterial killing (right panel) by WT and Casp-1−/− BMDMs 2 h postinfection. (C) Relative levels of LDH release (left panel) and bacterial killing (right panel) 2 h postinfection (MOI = 5) by BMDMs isolated from wild-type (C57bl6), Nlrp3−/−, Asc−/−, and IL-1β−/− mice (n = 3). Data shown are representative of the results from two or more animals. (D) ELISA shows IL-1β secreted by BMDMs isolated from wild-type (C57bl6), Nlrp3−/−, Asc−/−, and IL-1β−/− mice after 2 h coincubation with GAS at an MOI of 20. Data shown are representative of the results from two animals. (E) CD1 mice were infected with 7 × 105 CFU of WT or ΔspyA GAS (AP) via tail-vein injection (n = 7 per group). Immediately after infection, anakinra (IL-1 receptor antagonist) was subcutaneously injected at 100 mg/kg over a 12-h interval until the end of survival curve. WT plus saline solution versus ΔspyA plus saline solution, *, P = 0.04; WT plus saline solution versus WT plus anakinra. **, P = 0.0036; WT plus anakinra versus ΔspyA plus anakinra, P = 0.06; ΔspyA plus saline solution versus ΔspyA plus anakinra, P = 0.07 (log rank test with 95% confidence interval); N.S., not significant (P > 0.05). (F) GAS-infected mice (n = 8 to 10) were sacrificed 2 days postinfection; heart, spleen, and liver were harvested for CFU enumeration; no statistically significant differences were observed between WT and ΔspyA-infected animals that received anakinra treatment or for ΔspyA-infected animals with saline solution treatment. Closed symbols = WT; open symbols = ΔspyA. Black = control mice, red = anakinra-treated mice. Error bars, SEM. Statistical analysis: *, P < 0.05; N.S., not significant (P > 0.05) (Student’s two-tailed unpaired t test). (G) BMDMs in RPMI plus 2% FBS were treated with 1 or 10 ng/ml of recombinant mouse IL-1β (PeproTech, Rocky Hill, NJ) at the time of infection. Cells were washed and CFU recovered 2 h postinfection to assess bacterial killing. Error bars, SEM. *, P < 0.05; **, P = 0.01; ***, P < 0.001; NS, not significant; n = 3 (Student’s unpaired two-tailed t test).](https://figures.cochat.ai/paper-figures/463a0b3e0d224e0186b77aa95a4e25b3/a-group-a-streptococcus-adp-ribosyltransferase-toxin-stimulates-a-protective-figure-5.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“a Streptococcus ADP-ribosyltransferase, SpyA, triggers an IL-1β-dependent innate immune response pathway that is critical in defense against invasive bacterial infection (Lin et al., 2015).”
From The Heme Transporter HtsABC of Group A Streptococcus Contributes to Virulence and Innate Immune Evasion in Murine Skin Infections (2018) · cites this paper as Lin et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344 · cited 1×
“Because apoptosis is immunologically silent (13, 16, 20), we suspect that its activation by SpyA is secondary to the propyroptotic effect in the contexts considered in this study.”
BackgroundPyroptosis: host cell death and inflammation
Bergsbaken, T., Fink, S. L., & Cookson, B. T. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2070 · Cited by 3,183 · cited 13×
“Differences in bacterial recovery between WT P. aeruginosa infection and toxA mutant infection were abolished in BMDMs from NLRP3, ASC, and IL-1 knockout mice (Fig.”
BackgroundInfluentialThe global burden of group A streptococcal diseases
Carapetis, J. R., Steer, A. C., Mulholland, E. K., & Weber, M. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70267-x · Cited by 2,998 · cited 1×
“Streptococcus pyogenes (group A Streptococcus [GAS]) is a leading bacterial pathogen responsible for a broad array of human diseases, ranging from superficial infections such as pharyngitis (“strep throat”) to potentially life-threatening systemic conditions, including necrotizing fasciitis and streptococcal toxic sho…”
BackgroundGut inflammation provides a respiratory electron acceptor for Salmonella
Winter, S. E., Thiennimitr, P., Winter, M. G., Butler, B. P., Huseby, D. L., Crawford, R. W., Russell, J. M., Bevins, C. L., Adams, L. G., Tsolis, R. M., et al. (2010) · Nature · doi:10.1038/nature09415 · Cited by 1,290 · cited 1×
“, pharyngitis), it is possible that GAS activation of host inflammatory responses results in preferential clearance of normal microflora, upon which the pathogen with its larger arsenal of immune resistance factors can occupy the evacuated niche, similar to a recent paradigm shift in our understanding of Salmonella ga…”
Stecher, B., Robbiani, R., Walker, A. W., Westendorf, A. M., Barthel, M., Kremer, M., Chaffron, S., Macpherson, A. J., Buer, J., Parkhill, J., et al. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050244 · Cited by 1,048 · cited 1×
“, pharyngitis), it is possible that GAS activation of host inflammatory responses results in preferential clearance of normal microflora, upon which the pathogen with its larger arsenal of immune resistance factors can occupy the evacuated niche, similar to a recent paradigm shift in our understanding of Salmonella ga…”
Sensing and reacting to microbes through the inflammasomes
Franchi, L., Muñoz-Planillo, R., & Núñez, G. (2012) · Nature Immunology · doi:10.1038/ni.2231 · Cited by 1,012 · cited 4×
“Inflammasome responses restrict intracellular replication of numerous pathogens (13, 14, 16, 17), and failure to activate inflammasome oligomerization during microbial infections upon loss of a key inflammasome component(s) severely dampens macrophage killing, allowing accelerated bacterial replication (22, 23).”
BackgroundInfluentialIL‐1, IL‐18, and IL‐33 families of cytokines
Arend, W. P., Palmer, G., & Gabay, C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00624.x · Cited by 912
Inflammatory caspases and inflammasomes: master switches of inflammation
Martinon, F., & Tschopp, J. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402038 · Cited by 820 · cited 5×
“Differences in bacterial recovery between WT P. aeruginosa infection and toxA mutant infection were abolished in BMDMs from NLRP3, ASC, and IL-1 knockout mice (Fig.”
BackgroundInfluentialFlagellin-Deficient Legionella Mutants Evade Caspase-1- and Naip5-Mediated Macrophage Immunity
Ren, T., Zamboni, D. S., Roy, C. R., Dietrich, W. F., & Vance, R. E. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020018 · Cited by 535
IL-1β Processing in Host Defense: Beyond the Inflammasomes
Netea, M. G., Simon, A., van de Veerdonk, F., Kullberg, B.-J., Van der Meer, J. W. M., & Joosten, L. A. B. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000661 · Cited by 490
Sumby, P., Whitney, A. R., Graviss, E. A., DeLeo, F. R., & Musser, J. M. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020005 · Cited by 459 · cited 11×
“SpyA mediates caspase-1 signaling to stimulate the IL-1 cytokine release necessary for a subsequent increase in bacterial killing of invasive M1T1 GAS in macrophages.”
BackgroundInfluentialDNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection
Walker, M. J., Hollands, A., Sanderson-Smith, M. L., Cole, J. N., Kirk, J. K., Henningham, A., McArthur, J. D., Dinkla, K., Aziz, R. K., Kansal, R. G., et al. (2007) · Nature Medicine · doi:10.1038/nm1612 · Cited by 426 · cited 10×
“SpyA mediates caspase-1 signaling to stimulate the IL-1 cytokine release necessary for a subsequent increase in bacterial killing of invasive M1T1 GAS in macrophages.”
BackgroundInfluentialSelf-citationRecognition of Bacteria by Inflammasomes
von Moltke, J., Ayres, J. S., Kofoed, E. M., Chavarría-Smith, J., & Vance, R. E. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095944 · Cited by 421 · cited 1×
“Unlike apoptosis, which is activated by a subset of caspases, including caspase-3, the key regulator inducing pyroptosis is caspase-1 (15).”
BackgroundMolecular insight into invasive group A streptococcal disease
Cole, J. N., Barnett, T. C., Nizet, V., & Walker, M. J. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2648 · Cited by 377 · cited 1×
“With covRS mutation, transcription of several genes encoding GAS hyaluronic acid biosynthesis, cytotoxins, and immune evasion factors is upregulated, promoting neutrophil resistance and bloodstream survival and thereby increasing virulence (3, 4).”
BackgroundSelf-citationInflammasome-derived IL-1β production induces nitric oxide–mediated resistance to Leishmania
Lima-Junior, D. S., Costa, D. L., Carregaro, V., Cunha, L. D., Silva, A. L. N., Mineo, T. W. P., Gutierrez, F. R. S., Bellio, M., Bortoluci, K. R., Flavell, R. A., et al. (2013) · Nature Medicine · doi:10.1038/nm.3221 · Cited by 360
Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils
Kobayashi, S. D., Braughton, K. R., Whitney, A. R., Voyich, J. M., Schwan, T. G., Musser, J. M., & DeLeo, F. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1833375100 · Cited by 336 · cited 1×
“GAS, accelerated phagocyte apoptosis triggered by streptolysin is a known GAS virulence mechanism (35).”
BackgroundInflammasome-mediated pyroptotic and apoptotic cell death, and defense against infection
Aachoui, Y., Sagulenko, V., Miao, E. A., & Stacey, K. J. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.04.004 · Cited by 296
Iglewski, B. H., Liu, P. V., & Kabat, D. (1977) · Infection and Immunity · doi:10.1128/iai.15.1.138-144.1977 · Cited by 273
Dockrell, D. H., Marriott, H. M., Prince, L. R., Ridger, V. C., Ince, P. G., Hellewell, P. G., & Whyte, M. K. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5380 · Cited by 239
Harder, J., Franchi, L., Muñoz-Planillo, R., Park, J.-H., Reimer, T., & Núñez, G. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900444 · Cited by 237
Jayaraman, P., Sada-Ovalle, I., Nishimura, T., Anderson, A. C., Kuchroo, V. K., Remold, H. G., & Behar, S. M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202688 · Cited by 214
Hruz, P., Zinkernagel, A. S., Jenikova, G., Botwin, G. J., Hugot, J.-P., Karin, M., Nizet, V., & Eckmann, L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904958106 · Cited by 204
Self-citationAziz, R. K., Pabst, M. J., Jeng, A., Kansal, R., Low, D. E., Nizet, V., & Kotb, M. (2004) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03797.x · Cited by 196
Self-citationStreptolysin O Promotes Group A Streptococcus Immune Evasion by Accelerated Macrophage Apoptosis
Timmer, A. M., Timmer, J. C., Pence, M. A., Hsu, L.-C., Ghochani, M., Frey, T. G., Karin, M., Salvesen, G. S., & Nizet, V. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m804632200 · Cited by 183 · cited 1×
“formed as previously described (48), with minor modifications.”
MethodSelf-citationRise and Persistence of Global M1T1 Clone of Streptococcus pyogenes
Aziz, R. K., & Kotb, M. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1410.071660 · Cited by 183 · cited 1×
“Spontaneous mutations in the covRS (also called csrRS) two-component regulatory system arise during systemic dissemination of the M1T1 GAS clone, which has spread globally in recent decades as the leading strain associated with severe infections (2).”
BackgroundKansal, R. G., McGeer, A., Low, D. E., Norrby‐Teglund, A., & Kotb, M. (2000) · Infection and Immunity · doi:10.1128/.68.11.6362-6369.2000 · Cited by 179 · cited 1×
“In our well-characterized M1T1 GAS human invasive disease isolate (strain 5448) (25), real-time quantitative PCR (qPCR) results corroborated a 10-fold increase in spyA mRNA levels upon animal passage (see Fig.”
BackgroundMolecular Mechanisms of the Cytotoxicity of ADP-Ribosylating Toxins
Deng, Q., & Barbieri, J. T. (2008) · Annual Review of Microbiology · doi:10.1146/annurev.micro.62.081307.162848 · Cited by 176
High-frequency transformation ofStaphylococcus aureus by electroporation
Kraemer, G. R., & Iandolo, J. J. (1990) · Current Microbiology · doi:10.1007/bf02199440 · Cited by 168 · cited 1×
“aureus RN4220 with pDCerm or pDCerm-SpyA vectors following a previous protocol (44).”
BackgroundCole, J. N., Pence, M. A., von Köckritz‐Blickwede, M., Hollands, A., Gallo, R. L., Walker, M. J., & Nizet, V. (2010) · mBio · doi:10.1128/mbio.00191-10 · Cited by 134 · cited 10×
“SpyA mediates caspase-1 signaling to stimulate the IL-1 cytokine release necessary for a subsequent increase in bacterial killing of invasive M1T1 GAS in macrophages.”
BackgroundInfluentialSelf-citationHenry, T., & Monack, D. M. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.01022.x · Cited by 103 · cited 1×
“Inflammasome responses restrict intracellular replication of numerous pathogens (13, 14, 16, 17), and failure to activate inflammasome oligomerization during microbial infections upon loss of a key inflammasome component(s) severely dampens macrophage killing, allowing accelerated bacterial replication (22, 23).”
BackgroundAli, F., Lee, M. E., Iannelli, F., Pozzi, G., Mitchell, T. J., Read, R. C., & Dockrell, D. H. (2003) · The Journal of Infectious Diseases · doi:10.1086/378675 · Cited by 102
Hollands, A., Pence, M. A., Timmer, A. M., Osvath, S. R., Turnbull, L., Whitchurch, C. B., Walker, M. J., & Nizet, V. (2010) · The Journal of Infectious Diseases · doi:10.1086/653124 · Cited by 100 · cited 1×
“out mutant was constructed by an established protocol (41).”
MethodSelf-citationLin, A. E., Autran, C. A., Española, S. D., Bode, L., & Nizet, V. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit464 · Cited by 88 · cited 1×
“mega) was performed per the manufacturer’s protocol (47).”
MethodSelf-citationAli, S. R., Timmer, A. M., Bilgrami, S., Park, E. J., Eckmann, L., Nizet, V., & Karin, M. (2011) · Immunity · doi:10.1016/j.immuni.2011.04.015 · Cited by 84
Self-citationJenkins, C. E., Swiatoniowski, A., Issekutz, A. C., & Lin, T.-J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405594200 · Cited by 83 · cited 1×
“aeruginosa exotoxin A (PEA) is a well-characterized C3 family ADP-ribosyltransferase that targets host elongation factor 2 to induce a block in translation elongation (29) and programmed cell death (30, 31).”
BackgroundMühlen, K. A., Schümann, J., Wittke, F., Stenger, S., van Rooijen, N., Kaer, L. V., & Tiegs, G. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.3034 · Cited by 79 · cited 1×
“aeruginosa exotoxin A (PEA) is a well-characterized C3 family ADP-ribosyltransferase that targets host elongation factor 2 to induce a block in translation elongation (29) and programmed cell death (30, 31).”
BackgroundLeukocyte Inflammatory Responses Provoked by Pneumococcal Sialidase
Chang, Y., Uchiyama, S., Varki, A. P., & Nizet, V. (2012) · mBio · doi:10.1128/mbio.00220-11 · Cited by 72 · cited 1×
“aureus elicits a NOD2-dependent, IL1!-amplified, and IL-6-mediated protective immune response (38), anthrax lethal factor-mediated cell death triggered a protective ATP- and IL-1!-mediated host defense program (39), and pneumococcal neuraminidase is detected with ERK phosphorylation, NF-#B activation, interleukin-8 re…”
BackgroundSelf-citationHamilton, A., Robinson, C., Sutcliffe, I. C., Slater, J. D., Maskell, D. J., Davis-Poynter, N. J., Smith, K. C., Waller, A. S., & Harrington, D. J. (2006) · Infection and Immunity · doi:10.1128/iai.01116-06 · Cited by 63 · cited 1×
“(designated "spyA plus pSpyA) was achieved using prior protocols (43).”
MethodAn Overview of Interleukin-1 Receptor Antagonist, Anakinra, in the Treatment of Cutaneous Diseases
Pazyar, N., Feily, A., & Yaghoobi, R. (2012) · Current Clinical Pharmacology · doi:10.2174/157488412803305821 · Cited by 60 · cited 1×
“Anakinra (Kineret; 100 mg/kg of body weight), a nonglycosylated recombinant human IL-1 receptor antagonist, was administered at 12-h intervals to block IL-1 signaling in mice (28).”
MethodZheng, Y., Lilo, S., Mena, P., & Bliska, J. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036019 · Cited by 50 · cited 8×
“Here we report that GAS SpyA initiates caspase-1-dependent signaling to induce IL-1 release.”
BackgroundResultInfluentialIdentification of SpyA, a novel ADP‐ribosyltransferase of Streptococcus pyogenes
Coye, L. H., & Collins, C. M. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04262.x · Cited by 49
Icenogle, L. M., Hengel, S. M., Coye, L. H., Streifel, A., Collins, C. M., Goodlett, D. R., & Moseley, S. L. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.370791 · Cited by 39 · cited 4×
“Based on our finding that cells transfected with an activesite mutant allele, SpyAE187A, did not mediate effective bacterial clearance, we suspect that SpyA triggers IL-1! release related to perturbations caused by its ADP-ribosyltransferase activity on multiple host cell targets (12).”
BackgroundMethodInfluentialParameters Governing Invasive Disease Propensity of Non-M1 Serotype Group A Streptococci
Maamary, P. G., Sanderson‐Smith, M. L., Aziz, R. K., Hollands, A., Cole, J. N., McKay, F. C., McArthur, J. D., Kirk, J. K., Cork, A. J., Keefe, R. J., et al. (2010) · Journal of Innate Immunity · doi:10.1159/000317640 · Cited by 39 · cited 1×
“Hyperinvasive covRS derivatives are selected upon experimental challenge of mice with strain M1T1 (3, 5, 6) and other serotype GAS strains (7) and can be designated “animal-passaged” (AP) strains.”
BackgroundSelf-citationDetection of cytosolic bacteria by inflammatory caspases
Hagar, J. A., & Miao, E. A. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.11.008 · Cited by 30 · cited 6×
“Production of IL-1! is also essential to control intracellular growth of these microbes (14, 16, 18, 32).”
BackgroundInfluentialHoff, J. S., DeWald, M., Moseley, S. L., Collins, C. M., & Voyich, J. M. (2011) · Infection and Immunity · doi:10.1128/iai.01191-10 · Cited by 24 · cited 4×
“(10), while levels of intracellular survival of the WT and mutant bacteria were roughly equal over the ensuing 4 h (Fig.”
BackgroundInfluentialPolicing the cytosol—bacterial-sensing inflammasome receptors and pathways
Ng, T. M., Kortmann, J., & Monack, D. M. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.11.009 · Cited by 12 · cited 4×
“Inflammasome responses restrict intracellular replication of numerous pathogens (13, 14, 16, 17), and failure to activate inflammasome oligomerization during microbial infections upon loss of a key inflammasome component(s) severely dampens macrophage killing, allowing accelerated bacterial replication (22, 23).”
BackgroundInfluentialKorotkova, N., Hoff, J. S., Becker, D. M., Quinn, J. K. H., Icenogle, L. M., & Moseley, S. L. (2012) · Molecular Microbiology · doi:10.1111/j.1365-2958.2012.07979.x · Cited by 11 · cited 1×
“Researchers who performed earlier studies speculated that in early, localized infections, SpyA effects that cause epithelial cell damage such as cytoskeletal protein rearrangement and programmed cell death (9, 10, 12) may promote survival within a skin abscess.”
BackgroundLin, A. E., & Guttman, J. A. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.09.005 · Cited by 6
Self-citation
Research works printed but not linked: 1
- 10.1128/IAI.68.11.6362-6369.2000 · doi:10.1128/iai.68.11.6362-6369.2000 · Paper page
Cited by
Cytosolic Recognition of Microbes and Pathogens: Inflammasomes in Action
Hayward, J. A., Mathur, A., Ngo, C., & Man, S. M. (2018) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00015-18 · Cited by 164
IL-1β is an innate immune sensor of microbial proteolysis
LaRock, C. N., Todd, J., LaRock, D. L., Olson, J., O’Donoghue, A. J., Robertson, A. A. B., Cooper, M. A., Hoffman, H. M., & Nizet, V. (2016) · Science Immunology · doi:10.1126/sciimmunol.aah3539 · Cited by 162
Self-citationStreptococcal toxins: role in pathogenesis and disease
Barnett, T. C., Cole, J. N., Rivera-Hernández, T., Henningham, A., Paton, J. C., Nizet, V., & Walker, M. J. (2015) · Cellular Microbiology · doi:10.1111/cmi.12531 · Cited by 124
“In amouse intravenous infectionmodel, the ΔspyA mutant caused higher mortality with impaired bacterial clearance, and in vivo, the mutant was resistant to killing by macrophages (Lin et al., 2015).”
BackgroundSelf-citationGroup A streptococcal M protein activates the NLRP3 inflammasome
Valderrama, J. A., Riestra, A. M., Gao, N. J., LaRock, C. N., Gupta, N., Ali, S. R., Hoffman, H. M., Ghosh, P., & Nizet, V. (2017) · Nature Microbiology · doi:10.1038/s41564-017-0005-6 · Cited by 108
Self-citationCastiglia, V., Piersigilli, A., Ebner, F., Janos, M., Goldmann, O., Damböck, U., Kröger, A., Weiss, S., Knapp, S., Jamieson, A. M., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.02.003 · Cited by 110
Metadata
- Authors
- Lin, A. E., Beasley, F. C., Keller, N., Hollands, A., Urbano, R., Troemel, E. R., Hoffman, H. M., & Nizet, V.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Nizet, Victor
- Venue
- mBio
- Publisher
- American Society for Microbiology
- Published
- 2015-05
- Volume
- 6
- Issue
- 2
- Pages
- e00133-e00133
- ISSN
- 2150-7511 (ISSN-L)
- 2161-2129
- PMC
- PMC4453525
- OpenAlex
- W2108719850
- Cited by
- 46
- References
- 49
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 4 · 2022: 5 · 2021: 2 · 2020: 2 · 2019: 6 · 2018: 8 · 2017: 5 · 2016: 8 · 2015: 2
- FWCI
- 8.20
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-sa
- creativecommons.org/licenses/by-nc-sa/3.0/ (vor)
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- mBio (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health
- Canadian Institutes of Health Research
- National Institute of Allergy and Infectious Diseases (R01AI096837, AI077780, R01AI077780, U54AI057153, AI057153)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- Streptococcus pyogenes, IL-1β, caspase-1, macrophage cell death, NLRP3 inflammasome, ASC, invasive streptococcal infection, necrotizing fasciitis, septicemia, innate immune response
- MeSH terms
- Animals, Cell Survival, Disease Models, Animal, Macrophages, Streptococcal Infections, Streptococcus pyogenes, Virulence, Gene Deletion, ADP Ribose Transferases, Mice, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.